Limited clinical value of regular bone marrow cytogenetic analysis in imatinib-treated chronic phase CML patients monitored by RQ-PCR for BCR-ABL
収録刊行物
-
- Leukemia
-
Leukemia 20 (4), 664-670, 2006-02-16
Springer Science and Business Media LLC